BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28577624)

  • 41. Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations.
    Khan MJ
    Clin Obstet Gynecol; 2023 Sep; 66(3):470-477. PubMed ID: 37436937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European consensus statement on "HPV Vaccination and Colposcopy".
    Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
    J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A model for the implementation of cervical cancer screening and human papillomavirus vaccination in the ED: a pilot study.
    Devine AS; Mason J; Rankins N; Favor TT; Baur V; Parker R; Baddorf S; McCarthy M; Ford L; Cunningham TD
    Am J Emerg Med; 2016 Mar; 34(3):648. PubMed ID: 26851060
    [No Abstract]   [Full Text] [Related]  

  • 45. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
    de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
    J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management.
    Stumbar SE; Stevens M; Feld Z
    Prim Care; 2019 Mar; 46(1):117-134. PubMed ID: 30704652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
    Miller RA; Waters LL; Mody DR; Tams KC
    Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
    Poljak M; Ginocchio CC
    J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
    [No Abstract]   [Full Text] [Related]  

  • 51. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical Cancer Screening and Follow-Up Procedures in Women Age <21 Years Following New Screening Guidelines.
    Foxx AM; Zhu Y; Mitchel E; Nikpay S; Khabele D; Griffin MR
    J Adolesc Health; 2018 Feb; 62(2):170-175. PubMed ID: 29174874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
    Sundström K; Elfström KM
    PLoS Med; 2020 Jan; 17(1):e1003035. PubMed ID: 31990905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cervical cancer screening guidelines: An update.
    Shami S; Coombs J
    JAAPA; 2021 Sep; 34(9):21-24. PubMed ID: 34448772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US.
    Sonawane K; Suk R; Chiao EY; Schmeler KM; Montealegre J; Fernandez ME; Deshmukh AA
    JAMA Netw Open; 2021 Oct; 4(10):e2131129. PubMed ID: 34698852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACOG Practice Bulletin Number 131: Screening for cervical cancer.
    Committee on Practice Bulletins—Gynecology
    Obstet Gynecol; 2012 Nov; 120(5):1222-38. PubMed ID: 23090560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical Cancer Screening Guideline for Individuals at Average Risk.
    Chor J; Davis AM; Rusiecki JM
    JAMA; 2021 Dec; 326(21):2193-2194. PubMed ID: 34766970
    [No Abstract]   [Full Text] [Related]  

  • 60. Starting cervical cancer screening at 25 years of age: the time has come.
    Popadiuk C; Decker K; Gauvreau C
    CMAJ; 2019 Jan; 191(1):E1-E2. PubMed ID: 30617226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.